Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 7,133 shares at $136.22 ($967K) on 2018-05-14, disclosed to the SEC on 2018-05-16.
Open-market sale of $967k LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.18 | 2,000 | $268K | 27.8% |
| 2 | $135.08 | 2,050 | $277K | 28.6% |
| 3 | $136.22 | 1,525 | $208K | 21.5% |
| 4 | $137.28 | 1,558 | $214K | 22.1% |
| Total | $135.55 avg | 7,133 | $967K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |